Pancreas Cancer: The Current and the Future

Pancreas cancers are on the rise. Treatment paradigms are changing, and many novel approaches are under development in this disease. This one day live virtual course, in conjunction with MSK's Center for Pancreatic Cancer Research (CPCR), is very timely and will review the epidemiology, genomic, molecular and pathologic features of this disease along with discussing diagnostic and therapeutic approaches both pancreas adenocarcinoma and neuroendocrine tumors. The course will also discuss novel treatments and emerging directions and include a session on innovations in supportive care. An emphasis will be on multidisciplinary decision making and will include a case-based focus.

Who Should Attend

The course is designed for medical and surgical oncologists, gastroenterologists, internal medicine specialists, pathologists, geneticists, pharmacists, supportive care staff, nursing, advanced practice practitioners, trainees and other disciplines. MSK is pleased to invite patients to attend this course on a complimentary basis (details below).

Live Virtual Format

1. Describe the pathologic, genetic and molecular hallmarks of pancreas cancer
2. Identify the importance of and where to optimally utilize multidisciplinary care for management of pancreas cancer
3. Outline current diagnostic and surgical strategies for pancreas cancer
4. Review the indications and implications of germline and somatic testing in pancreas cancer
5. Define the key novel therapeutic approaches for management of pancreas cancer and neuroendocrine tumors of the pancreas
6. Review new innovations in supportive care approaches for pancreas cancer

Virtual Registration Fees

• Physicians (MDs, PhDs and DOs): $175
• Advanced Practice Providers (NPs, PAs, CRNAs): $150
• Residents, Fellows, Nurses and Other Healthcare Providers: $100
• Industry Professionals*: $300
• Patients**: complimentary; please see details below.

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

Discounts/Promotions

• **MSK is pleased to invite patients to attend this course on a complimentary basis. If you are a patient interested in attending, please email [email protected] to register (registration is required in order to attend).
• A registration discount is available for MSK Alumni, MSK Cancer Alliance, and Cancer Care Partners to attend a MSK CME course. If you are a member of one of these groups, contact [email protected] for details.
• Registration is complimentary for all MSK employees; however, you must complete registration through the 'Register' tab above in order to attend this course. If you are registered for this course and are unable to attend, please notify [email protected].

Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

Online Registration Deadline 

Online registration is available on the MSK CME Portal until 6:00 AM on November 3, 2021. If you wish to register after this date, please email [email protected] and we will ensure your registration is processed as well as access instructions are emailed to you prior to the start of the course.

Cancellation Policy

For all other registrations: If you wish to cancel your participation in this course, you must email [email protected] at least seven (7) days prior to the start of the course, and your refund will be subject to a $25 administrative fee. Cancellations or no-shows within seven (7) days of the course are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MSK Course Director

Eileen M. O’Reilly, MD
Winthrop Rockefeller Endowed Chair in Medical Oncology
Section Head, Hepatopancreaticobiliary and Neuroendocrine Cancers
Co-Director Medical Initiatives, David M. Rubenstein Center for Pancreatic Cancer
Attending Physician, Member, Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College

MSK Course Co-directors

Robin B. Brenner, RN, OCN 
Pancreas Cancer Clinical Trials Nurse III
David M. Rubenstein Center for Pancreatic Cancer Research 
Memorial Sloan Kettering Cancer Center

Christine Iacobuzio-Donahue MD PhD
Director, David M. Rubenstein Center for Pancreatic Cancer Research
Attending, Department of Pathology
Memorial Sloan Kettering Cancer Center

Alice C Wei, MD MSc FRCSC
Associate Attending Surgeon
Co-Director of Surgical Initiatives, David M. Rubenstein Center for Pancreatic Cancer Research
Memorial Sloan Kettering Cancer Center

Invited Keynote Speaker & David M. Rubenstein Award Lecture

David A. Tuveson M.D., Ph.D, FAACR
Director, Cold Spring Harbor Laboratory Cancer Center
Roy J. Zuckerberg Professor of Cancer Research
Chief Scientist, The Lustgarten Foundation 
President, American Association for Cancer Research (AACR)

Invited Course Faculty 

Lily V. Saadat, MD
General Surgery Resident
Brigham and Women’s Hospital

David A. Tuveson MD, PhD, FAACR
Director, Cold Spring Harbor Laboratory Cancer Center
Roy J. Zuckerberg Professor of Cancer Research
Chief Scientist, The Lustgarten Foundation 
President, American Association for Cancer Research (AACR)

MSK Course Faculty 

Fiyinfolu Balogun, MD, PhD
Assistant Attending Physician 
Gastrointestinal Oncology Service
Department of Medicine 

Olca Basturk, MD
Associate Attending Pathologist
Memorial Sloan Kettering Cancer Center
Associate Professor of Pathology and Laboratory Medicine
Weill-Cornell School of Medicine, Cornell University

Michael F. Berger, PhD
Associate Director, Marie-Josée and Henry R. Kravis Center for Molecular Oncology 
Attending Pathologist 
Diagnostic Molecular Pathology Service
Department of Pathology  

Mengmeng (Margaret) Du, ScD
Assistant Attending Epidemiologist
Department of Epidemiology-Biostatistics

Cecilia G. Ethun, MD, MS
Fellow, Complex General Surgical Oncology
Leslie H. Blumgart Fellow, Hepatopancreatobiliary Surgery

James Flory, MD
Assistant Attending Endocrinologist
Endocrinology Service
Department of Medicine

David Paul Kelsen, MD
Edward S. Gordon Chair in Medical Oncology 
Attending Physician
Gastrointestinal Oncology Service
Department of Medicine

Richard Kinh Gian Do, MD, PhD
Associate Attending Radiologist
Body Imaging Service 
Department of Radiology  

Jun J. Mao, MD, MSCE
Chief Attending
Integrative Medicine Service
Department of Medicine 

Wungki Park, MD
Assistant Attending Physician
Gastrointestinal Oncology Service
Department of Medicine 

Diane Reidy-Lagunes, MD
Associate Deputy Physician-in-Chief, Regional Care Associate Attending Physician
Gastrointestinal Oncology Service
Department of Medicine 

Vineet Syan Rolston, MD
Assistant Attending Gastroenterologist
Gastroenterology, Hepatology and Nutrition Service
Department of Medicine 

Reggie T. Saldivar, MD
Director of Telehealth, Supportive Care Service
Associate Program Director, Hospice and Palliative Medicine Fellowship
Assistant Professor of Clinical Medicine, Weill Cornell Medical College 

Mark A. Schattner, MD, FASGE, AGAF
Chief Attending
Gastroenterology, Hepatology and Nutrition Service
Department of Medicine 

Joshua D. Schoenfeld, MD, PhD
Postdoctoral Fellow
Vardhana/Wolchok Laboratories 

Kevin Soares, MD
Assistant Attending Surgeon
Hepatopancreatobiliary Service
Department of Surgery  

Zsofia K. Stadler, MD
Associate Attending Physician
Clinical Genetics Service
Gastrointestinal Oncology Service
Department of Medicine

Anna M. Varghese, MD
Assistant Attending Physician
Gastrointestinal Oncology Service
Department of Medicine

Kenneth H. Yu, MD, MSc
Associate Attending Physician
Gastrointestinal Oncology Service
Department of Medicine

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of an ACE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Memorial Sloan Kettering gratefully acknowledges the following organizations for providing educational grants for this live activity:

AstraZeneca